Cargando…

Molecular profiling of small renal masses: Current status and future directions

Small renal masses (SRMs) are renal tumors less than 4 cm in diameter. These account for the largest proportion of newly diagnosed renal cell cancers (RCC). Management of SRMs can be a dilemma if the patient is unfit to undergo partial nephrectomy. Molecular profiling enables better characterization...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalyanaraman, Balaji, Gaitonde, Krishnanath, Donovan, James F.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808653/
https://www.ncbi.nlm.nih.gov/pubmed/19955674
http://dx.doi.org/10.4103/0970-1591.57922
_version_ 1782176519668367360
author Kalyanaraman, Balaji
Gaitonde, Krishnanath
Donovan, James F.
author_facet Kalyanaraman, Balaji
Gaitonde, Krishnanath
Donovan, James F.
author_sort Kalyanaraman, Balaji
collection PubMed
description Small renal masses (SRMs) are renal tumors less than 4 cm in diameter. These account for the largest proportion of newly diagnosed renal cell cancers (RCC). Management of SRMs can be a dilemma if the patient is unfit to undergo partial nephrectomy. Molecular profiling enables better characterization of RCC and prediction of outcomes in terms of recurrence and progression. This article reviews the existing literature on molecular profiling of localized RCC, discusses limitations of molecular profiling, and presents the likely role that molecular profiling will play in guiding the treatment of SRMs.
format Text
id pubmed-2808653
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28086532010-01-25 Molecular profiling of small renal masses: Current status and future directions Kalyanaraman, Balaji Gaitonde, Krishnanath Donovan, James F. Indian J Urol Symposium Small renal masses (SRMs) are renal tumors less than 4 cm in diameter. These account for the largest proportion of newly diagnosed renal cell cancers (RCC). Management of SRMs can be a dilemma if the patient is unfit to undergo partial nephrectomy. Molecular profiling enables better characterization of RCC and prediction of outcomes in terms of recurrence and progression. This article reviews the existing literature on molecular profiling of localized RCC, discusses limitations of molecular profiling, and presents the likely role that molecular profiling will play in guiding the treatment of SRMs. Medknow Publications 2009 /pmc/articles/PMC2808653/ /pubmed/19955674 http://dx.doi.org/10.4103/0970-1591.57922 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Kalyanaraman, Balaji
Gaitonde, Krishnanath
Donovan, James F.
Molecular profiling of small renal masses: Current status and future directions
title Molecular profiling of small renal masses: Current status and future directions
title_full Molecular profiling of small renal masses: Current status and future directions
title_fullStr Molecular profiling of small renal masses: Current status and future directions
title_full_unstemmed Molecular profiling of small renal masses: Current status and future directions
title_short Molecular profiling of small renal masses: Current status and future directions
title_sort molecular profiling of small renal masses: current status and future directions
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808653/
https://www.ncbi.nlm.nih.gov/pubmed/19955674
http://dx.doi.org/10.4103/0970-1591.57922
work_keys_str_mv AT kalyanaramanbalaji molecularprofilingofsmallrenalmassescurrentstatusandfuturedirections
AT gaitondekrishnanath molecularprofilingofsmallrenalmassescurrentstatusandfuturedirections
AT donovanjamesf molecularprofilingofsmallrenalmassescurrentstatusandfuturedirections